3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
8
Carcinoma, Non-Small-Cell Lung
6
Breast Neoplasms
5
Pancreatic Neoplasms
4
Neoplasms
4
Colorectal Neoplasms
4
Stomach Neoplasms
3
Prostatic Neoplasms
3
Head and Neck Neoplasms
3
Esophageal Neoplasms
3
Carcinoma, Basal Cell
3
Barrett Esophagus
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Neuroendocrine Tumors
2
Lung Neoplasms
2
Liver Neoplasms
2
Inflammatory Bowel Diseases
2
Colonic Neoplasms
2
Breast Neoplasms, Male
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Tuberculosis
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Squamous Intraepithelial Lesions
1
Small Cell Lung Carcinoma
1
Interventions
Ipilimumab
3
Triamcinolone Acetonide
2
Ranibizumab
2
Nivolumab
2
Amplified Fragment Length Polymorphism Analysis
2
treosulfan
1
salicylhydroxamic acid
1
aldesleukin
1
Ultrasonography
1
Tramadol
1
Temozolomide
1
Tamoxifen
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sunitinib
1
Sorafenib
1
Rose Bengal
1
Radiosurgery
1
Physical Examination
1
Pharmacogenomic Testing
1
Interviews as Topic
1
Immunotherapy
1
Ibuprofen
1
Gemcitabine
1
Eye Enucleation
1
Cyclophosphamide
1
Cisplatin
1
Chemotherapy, Adjuvant
1
CTLA-4 Antigen
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Uveal Melanoma
×
Biopsy
×
Clear all
NCT02654821
2018-11-02
TCR
The Netherlands Cancer Institute
Phase 1/2
Unknown
12 enrolled